| Trial name or title | Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients |
| Methods | 24‐week, Randomized, Double‐blind, Placebo‐controlled, Parallel Group Study |
| Participants | 120 APOE e4 Positive Amnestic MCI Patients 55‐85 years Men and women |
| Interventions | 1. Rivastigmine patch 2. Placebo |
| Outcomes | Change in BOLD response on Functional Magnetic Resonance Imaging |
| Starting date | June 2011 |
| Contact information | Christine Reece, B.S., CCRP (raolab@ccf.org) |
| Notes | The primary outcome of this trial ("to determine if task‐activated fMRI is sensitive to the central cholinergic deficit associated with Mild Cognitive Impairment") is not relevant to this review but they may report secondary outcomes which could be relevant. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.